Frontiers of Medicine in China

, Volume 4, Issue 3, pp 271–274

Current situation and development of prenatal diagnosis in China

Review

Abstract

Prenatal screening and diagnosis are major methods for control of birth defects, which is a very important problem in China. Here, we review current situation and development of prenatal screening and diagnosis in mainland China, including prenatal screening and prenatal diagnosis of fetal chromosome abnormalities, non-invasive prenatal diagnostic techniques and prenatal diagnosis of monogenic diseases, polygenic disease and congenital metabolic diseases. We also discuss epidemiology of birth defects and genetic diseases in China and related ethical issues of prenatal diagnosis.

Keywords

prenatal diagnosis prenatal screening China 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Bian XM, Liu J T, Qi Q W, Jiang Y L, Li Y, Liu S Y, Hao N, Zhou J, Lü SM, Zhu B S, Wang H, Xu Z F, Pan X Y, Liao C, Cai Y, Wang H, Wang Z, Zhu J, Hu Y L. Second trimester maternal serum screening for Down’s syndrome in mainland China: a multi-center prospective study. Zhonghua Fu Chan Ke Za Zhi, 2008, 43(11): 805–809 (in Chinese)PubMedGoogle Scholar
  2. 2.
    Cowans N J, Spencer K. First-trimester ADAM12 and PAPP-A as markers for intrauterine fetal growth restriction through their roles in the insulin-like growth factor system. Prenat Diagn, 2007, 27(3): 264–271CrossRefPubMedGoogle Scholar
  3. 3.
    Wald N J, Rodeck C, Hackshaw A K, Rudnicka A. SURUSS in perspective. BJOG, 2004, 111(6): 521–531CrossRefPubMedGoogle Scholar
  4. 4.
    Malone F D, Canick J A, Ball R H, Nyberg D A, Comstock C H, Bukowski R, Berkowitz R L, Gross S J, Dugoff L, Craigo S D, Timor-Tritsch I E, Carr S R, Wolfe H M, Dukes K, Bianchi D W, Rudnicka A R, Hackshaw A K, Lambert-Messerlian G, Wald N J, D’Alton M E; First- and Second-Trimester Evaluation of Risk (FASTER) Research Consortium. First-trimester or second-trimester screening, or both, for Down’s syndrome. New Engl J Med, 2005, 353(19): 2001–2011CrossRefPubMedGoogle Scholar
  5. 5.
    Poon L L, Leung T N, Lau T K, Chow K C, Lo Y M D. Differential DNA methylation between fetus and mother as a strategy for detecting fetal DNA in maternal plasma. Clin Chem, 2002, 48(1): 35–41PubMedGoogle Scholar
  6. 6.
    Li L, Zhou Y Q, Xiao Q Z, Yan T Z, Xu X M. Development and evaluation of a reverse dot blot assay for the simultaneous detection of six common Chinese G6PD mutations and one polymorphism. Blood Cells Mol Dis, 2008, 41(1): 17–21CrossRefPubMedGoogle Scholar
  7. 7.
    Yi P, Yu F, Huang S, Zhong C, Li Q, Yang Y, Zhang W, Xiao C, Xu X. Identification of a novel frameshift mutation at codon 53 (-T) in the beta-globin gene causing dominantly inherited beta-thalassemia in a Chinese Miao family. Blood Cells Mol Dis, 2008, 41(1): 56–59CrossRefPubMedGoogle Scholar
  8. 8.
    Zeng F, Ren Z R, Huang S Z, Kalf M, Mommersteeg M, Smit M, White S, Jin C L, Xu M, Zhou D W, Yan J B, Chen M J, van Beuningen R, Huang S Z, den Dunnen J, Zeng Y T, Wu Y. Array-MLPA: comprehensive detection of deletions and duplications and its application to DMD patients. Hum Mutat, 2008, 29(1): 190–197CrossRefPubMedGoogle Scholar
  9. 9.
    Yin S, Na Q, Chen J, Li-Ling J, Liu C. Contribution of MRI to detect further anomalies in fetal ventriculomegaly. Fetal Diagn Ther, 2010, 27(1): 20–24CrossRefPubMedGoogle Scholar

Copyright information

© Higher Education Press and Springer-Verlag Berlin Heidelberg 2010

Authors and Affiliations

  1. 1.Department of Obstetrics and GynecologyPeking Union Medical College HospitalBeijingChina

Personalised recommendations